G1 THERAPEUTICS, INC. Retained Earnings
G1 THERAPEUTICS, INC. had Retained Earnings of -$795.67 million as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-08-08
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$795.67M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$790.20M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$779.99M.
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$769.11M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2024-06-30 | -$795.67M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$790.20M 10-Q · filed 2024-05-01 |
| 2023-12-31 | -$779.99M 10-Q · filed 2024-08-08 |
| 2023-09-30 | -$769.11M 10-Q · filed 2023-11-01 |
| 2023-06-30 | -$750.90M 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$759.61M 10-Q · filed 2023-05-03 |
| 2022-12-31 | -$732.02M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$698.37M 10-Q · filed 2022-11-02 |
| 2022-06-30 | -$673.10M 10-Q · filed 2022-08-03 |
| 2022-03-31 | -$633.65M 10-Q · filed 2022-05-04 |
| 2021-12-31 | -$584.46M 10-K · filed 2023-03-01 |
| 2021-09-30 | -$544.44M 10-Q · filed 2021-11-03 |
| 2021-06-30 | -$501.97M 10-Q · filed 2021-08-04 |
| 2021-03-31 | -$462.55M 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$436.11M 10-K · filed 2022-02-23 |
| 2020-09-30 | -$410.76M 10-Q · filed 2020-11-04 |
| 2020-06-30 | -$399.09M 10-Q · filed 2020-08-05 |
| 2020-03-31 | -$367.88M 10-Q · filed 2020-05-06 |
| 2019-12-31 | -$336.85M 10-K · filed 2021-02-24 |
| 2019-09-30 | -$301.41M 10-Q · filed 2019-11-05 |
| 2019-06-30 | -$269.05M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$238.36M 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$214.41M 10-K · filed 2020-02-26 |
| 2018-09-30 | -$190.31M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$170.40M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$149.53M 10-Q · filed 2018-05-03 |
| 2017-12-31 | -$129.12M 10-K · filed 2019-02-28 |
| 2017-09-30 | -$112.14M 10-Q · filed 2017-11-08 |
| 2017-06-30 | -$96.54M 10-Q · filed 2017-08-09 |
| 2016-12-31 | -$64.98M 10-K · filed 2018-02-21 |